Thus, micronodular adrenal hyperplasia, pituitary microadenoma, papillary thyroid cancer, uterine, ovarian, and retroperitoneal (FATWO) lesions are possible after-effects of CHEK2 missense mutation identified in the patient. The gene discussed is CHEK2; the disease is congenital adrenal hyperplasia.